← Back to all trials
Active Not Recruiting
NCT07606898
Fractional Exhaled Nitric Oxide as Possible Non - Invasive Biomarker to Assess Obstructive Sleep Apnea Severity
Conditions: Obstructive Sleep Apnea (OSA)
Sex: All
Ages: 18 Years – 70 Years
Healthy volunteers: Yes
Enrollment: 200
Sponsor: Tanta University
Location: Tanta University Tanta
Summary
Aim of work
1. Primary aim: Asses correlation between FeNO level, OSA severity
2. Secondary aim: Clarifying FeNO's role as a biomarker to assess airway inflammation, Cut off value prediction to moderate and severe OSA and its potential significance to improve clinical management strategies for OSA patients.
Eligibility Criteria
Inclusion Criteria:
* Ages Eligible for study: 18 years till 70 years old.
* Newly suspected OSA patients with Epworth Sleepiness Scale (ESS) ≥ 10.
Exclusion Criteria:
* Current smokers.
* Any chronic Respiratory disorders other than OSA (asthma, COPD, allergic rhinitis, and atopic diseases).
* Younger age than 18 years.
* Recent inhaled or systemic corticosteroids within the pasr 4 weeks.
* Recent respiratory infection less than 4 weeks.
* Uncontrolled diabetes \& any chronic debilitating diseases (liver, renal, collagen diseases) Informed Consent will be taken from the participants before clinical examination.
Source: ClinicalTrials.gov (NCT07606898). StuddyBuddy aggregates publicly available trial information.
